Hepatitis C Screening Alerts - Trial NCT05710120
Access comprehensive clinical trial information for NCT05710120 through Pure Global AI's free database. This phase not specified trial is sponsored by Epividian and is currently Enrolling by invitation. The study focuses on Hepatitis C. Target enrollment is 100000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Epividian
Timeline & Enrollment
N/A
Jan 16, 2023
Oct 01, 2023
Primary Outcome
Screening to Diagnosis Ratio for Hepatitis C Infection
Summary
The objective of this study is to evaluate whether alerts that identify patients without
 hepatitis C infection to healthcare providers and clinic staff can increase the uptake of
 screening for hepatitis C. A period of time without alerts will be compared to a period of
 time with alerts.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05710120
Non-Device Trial